Results showed that the risk of lymph node metastasis and distant metastasis in high PVT1 expression group was 2.83 and 3.60 folds than those with low PVT1 expression group, respectively. This evidence concerns the gene PVT1 and metastatic malignant neoplasm in the lymph nodes.